David C. Hastings - Chief Financial Officer at Arbutus Biopharma Corp

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
ABUS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David C. Hastings since 13 Aug 2025

Reported holdings for David C. Hastings in Arbutus Biopharma Corp

Form 4 holding Chief Financial Officer

Arbutus Biopharma Corp

Security class
Common Shares
Shares / value
249,824
Estimated value
$820,172
Report date
14 Feb 2025
Price
$3.28
Ownership
Direct
Form 4 holding Chief Financial Officer

Arbutus Biopharma Corp

Security class
Stock Option (Right to Buy)
Shares / value
365,800
Estimated value
Report date
14 Feb 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Transaction history for David C. Hastings in Arbutus Biopharma Corp

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .